Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2022

Key Information As of 04/19/24

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $57.90 million
NAV $28.11
Fact Sheet View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 04/18/24

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 2,060,000
Number of Holdings 0
30-Day Median Bid-Ask Spread 0.34%

Distributions As of 04/19/24

30-Day SEC Yield 0.75%
Distribution Frequency Semi-Annually

ETF Prices As of 04/19/24

NAV $28.11 Daily Change -$0.03 -0.11%
Market Price $28.24 Daily Change $0.06 0.21%

Performance History

As of recent month & quarter-end (03/31/24)
As of recent month & quarter-end (03/31/24)
Fund NAV Market Price Index
1 Year 12.59% 13.50% 12.98%
3 Years 3.44% 3.51% 3.67%
5 Years 7.66% 7.65% 7.90%
Since Inception 9.77% 10.13% 10.05%
1 Year 12.59% 13.50% 12.98%
3 Years 3.44% 3.51% 3.67%
5 Years 7.66% 7.65% 7.90%
Since Inception 9.77% 10.13% 10.05%
Year-to-Date 5.09% 5.87% 5.14%
1 Month 2.64% 2.10% 2.74%
3 Months 5.09% 5.87% 5.14%
Since Inception 108.76% 114.23% 113.11%
Year-to-Date 5.09% 5.87% 5.14%
1 Month 2.64% 2.10% 2.74%
3 Months 5.09% 5.87% 5.14%
Since Inception 108.76% 114.23% 113.11%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 03/31/24

Sector Weight (%)
Health Care 93.4
Real Estate 6.6

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Medical Specialties 37.1
Pharmaceuticals: Major 26.3
Biotechnology 17.4
Pharmaceuticals: Other 7.2
Real Estate Investment Trusts 7.1
Medical/Nursing Services 2.7
Hospital/Nursing Management 1.5
Electrical Products 0.4
Telecommunications Equipment 0.3

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 58.7
Switzerland 8.2
Japan 8.1
Denmark 7.0
Britain 3.9
Ireland 3.3
China 3.2
Belgium 1.9
South Korea 1.6
Australia 1.0
Canada 0.8
Other 2.3

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 04/18/24

Return on Equity 13.80%
Weighted Avg. Market Cap 133,613 M
2023 2024
Price-to-earnings 25.94 22.38
Price-to-book value 3.23 2.96

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 03/31/24

Versus Beta
S&P 500 0.72
NASDAQ-100 0.50
MSCI Emg. Mkts 0.53
Standard Deviation 16.20%

Source: new windowAltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.